The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

9 Sep 2011 15:15

RNS Number : 9824N
J.P. Morgan Private Equity Ltd
09 September 2011
 



 

 

J.P. MORGAN PRIVATE EQUITY LIMITED ANNOUNCESAPPROVAL OF ACQUISITION OF A PORTFOLIO OF PRIVATE EQUITY CO-INVESTMENTSBY THE SPL FUNDS AND ISSUE OF EQUITY

 

ALL SHARE TRANSACTION VALUED AT APPROXIMATELY US$91.9 MIllION

 

* * *

 

·; SPL Funds have announced that their shareholders have voted in favour of the proposed acquisition by JPEL

·; All-stock acquisition of portfolio of 38 mid-market buyout co-investments

·; £56.5 million purchase price using £36.7 million of US$ Equity Shares and £19.8 million of a new class of ZDP Shares due 2017

·; Purchase price represents a discount to 30 June 2011 Co-Investment Portfolio NAV

·; Acquisition is expected to be accretive to JPEL NAV and enhance 2013 and 2015 ZDP Share cover

·; Expected to generate positive growth and distributions from near-term exits

o Repositions JPEL's portfolio: adds mid-market buyout assets, primarily in the UK, Germany and France

o Enhances JPEL's balance sheet: adds mature assets with meaningful liquidity in 1-2 years

o Differentiates JPEL amongst secondary players and listed private equity peers

·; JPEL has allotted and issued to the SPL Funds, conditional only upon Admission, 44,727,053 new US$ Equity Shares and 30,410,753 New 2017 ZDP Shares

·; It is expected that the new shares will be admitted to listing and to trading at 8.00 a.m. on 12 September 2011

 

 

GUERNSEY, 9 SEPTEMBER 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is very pleased to announce that the SPL Funds, as sellers, have today announced that their shareholders have voted in favour the proposed acquisition by JPEL of the SPL Funds' limited partnership interests (the "Acquisition") in a portfolio of co-investments ("Co-Investment Portfolio").

 

The Co-Investment Portfolio is managed by Parallel Private Equity Limited Partnership and consists of a pool of 38 middle-market co-investments with leading fund managers primarily invested in the UK, Germany and France.

 

JPEL announced the all-share transaction valued at £56.5 million or approximately US$91.9 million on 16 August 2011.

 

The Acquisition is unconditional in all material respects other than admission of the new US$ Equity Shares (JPEL.LN) and New 2017 ZDP Shares (JPSZ.LN) (to be issued as consideration for the Acquisition) to listing on the UKLA's Official List and to trading on the London Stock Exchange ("Admission").

 JPEL can confirm that it has today allotted and issued to the SPL Funds, conditional only upon Admission, 44,727,053 new US$ Equity Shares and 30,410,753 New 2017 ZDP Shares. It is expected that the new shares will be admitted to listing and to trading at 8.00 a.m. on 12 September 2011.Unless otherwise defined in this announcement, defined terms contained herein shall have the meaning given to them in the Company's announcement relating to the Acquisition on 16th August 2011.

 

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1151 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

Peregrine Communications

Anthony Payne: Tel (Direct): +44 203 178 6869 (anthony.payne@peregrinecommunications.com)

 

Liberum Capital Limited (Sponsor to the Company and Broker to the Placing)

Steve Pearce / Tom Fyson / Christopher Britton: Tel (Direct): +44 (0)20 3100 2000

 

* * *

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated closed-ended investment company and is designed primarily to invest in the global private equity market. The Company's issued share capital has been admitted to listing on the premium segment and the standard segment (as appropriate) of the Official List and admitted to trading on the main market of the London Stock Exchange (LSE:JPEL, JPEZ, JPZZ, JPWW). In summary, the investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGURCBUPGGWB
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.